Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 10, Issue 2-4, Pages 71-81

Ablation of NK Cell Function During Tumor Growth Favors Type 2-Associated Macrophages, Leading to Suppressed CTL Generation

Laboratory of Cellular Immunology, Free University of Brussels, Flemish Interuniversity Institute for Biotechnology, B-1640 St.-Genesius Rode, Belgium

Copyright © 2003 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • John Richards, Beth McNally, Xianfeng Fang, Michael A. Caligiuri, Pan Zheng, and Yang Liu, “Tumor growth decreases NK and B cells as well as common lymphoid progenitor,” PLoS ONE, vol. 3, no. 9, 2008. View at Publisher · View at Google Scholar
  • Soo-Ray Wang, Stephen Hou, Amy Wang, Yu-Jun Chang, Cheng-Tzu Liu, Gregory J. Tsay, and Chung-Cheng Wei, “The Significance of Arginase I Administration on the Survival of Mice Bearing NS-1 Myeloma Cells,” Journal of Surgical Research, vol. 151, no. 1, pp. 28–32, 2009. View at Publisher · View at Google Scholar
  • G Comito, E Giannoni, C P Segura, P Barcellos-de-Souza, M R Raspollini, G Baroni, M Lanciotti, S Serni, and P Chiarugi, “Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression,” Oncogene, 2013. View at Publisher · View at Google Scholar
  • Camille Guillerey, and Mark J. Smyth, “Cancer Immunosurveillance by Natural Killer Cells and Other Innate Lymphoid Cells,” Oncoimmunology, pp. 163–180, 2017. View at Publisher · View at Google Scholar